Literature DB >> 2497664

Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease.

C L Emerman1, A F Connors, T W Lukens, D Effron, M E May.   

Abstract

Previous studies have established spirometric criteria for arterial blood gas analysis during acute asthmatic attacks. However, only general guidelines have been available regarding the need for blood gas analysis during an acute exacerbation of chronic obstructive pulmonary disease (COPD). We conducted a study to determine the relationship between arterial blood gases and spirometry in 70 emergency department patients during acute exacerbations of COPD. Arterial blood gas analysis and spirometry were performed on arrival at the emergency department. All of the patients with a pCO2 of more than 45 mm Hg had an FEV1 of less than 35% of the predicted normal. We found patients with a pO2 of less than 60 mm Hg who had an FEV1 as high as 54% of the predicted normal. There was no correlation between the FEV1 and pO2. Because spirometry was not reliable for identifying patients with significant hypoxemia, we conclude that arterial blood gas analysis is indicated for patients presenting to the ED with acute exacerbations of COPD. Spirometric criteria that have been used to eliminate the need for arterial blood gases in asthmatic patients cannot be applied safely to patients with COPD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497664     DOI: 10.1016/s0196-0644(89)80837-6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  8 in total

1.  Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Authors:  Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

2.  Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.

Authors:  Ian G Stiell; Catherine M Clement; Shawn D Aaron; Brian H Rowe; Jeffrey J Perry; Robert J Brison; Lisa A Calder; Eddy Lang; Bjug Borgundvaag; Alan J Forster; George A Wells
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

3.  Utility of pulmonary function testing in the management of chronic obstructive pulmonary disease.

Authors:  J E Casanova; J Kaufman
Journal:  J Gen Intern Med       Date:  1993-08       Impact factor: 5.128

4.  Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Zoe Kopsaftis; Kristin V Carson-Chahhoud; Michael A Austin; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2020-01-14

Review 5.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

6.  Markers of exacerbation severity in chronic obstructive pulmonary disease.

Authors:  Luigi G Franciosi; Clive P Page; Bartolome R Celli; Mario Cazzola; Michael J Walker; Meindert Danhof; Klaus F Rabe; Oscar E Della Pasqua
Journal:  Respir Res       Date:  2006-05-10

7.  Is hypercapnea a predictor of better survival in the patients who underwent mechanical ventilation for chronic obstructive pulmonary disease (COPD)?

Authors:  Joo Hun Park; Younsuck Koh; Chae-Man Lim; Sang-Bum Hong; Yeon Mok Oh; Tae Sun Shim; Sang Do Lee; Woo Sung Kim; Dong Soon Kim; Won Dong Kim
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

8.  Predictors of requirement of mechanical ventilation in patients with chronic obstructive pulmonary disease with acute respiratory failure.

Authors:  S Kumar; G C Khilnani; A Banga; S K Sharma
Journal:  Lung India       Date:  2013-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.